4Dmedical is revolutionizing medical imaging with its cutting-edge technology, which provides unparalleled insights into lung health. Our innovative approach enables healthcare professionals to visualize and understand complex respiratory conditions like never before.
View the entire 4DMedical portfolio.
Networking Opportunities: Connect with our team of specialists and fellow professionals to exchange ideas and insights
We invite you to visit the 4DMedical booth at the upcoming RSNA Annual Meeting for two unique experiences:
1. Virtual Reality XV Scanner Experience
See our latest technology through a Virtual Reality demonstration of the XV Scanner, providing you with a unique perspective on respiratory functions.
2. 10-minute Lung Health Analysis Software Demonstrations
Join us for product demos of our analysis software, designed to give you new, actionable insights into lung health that you can share with your ordering physicians. Our tools are built to enhance your diagnostic capabilities and support better patient care.
“Innovation, Partnerships—for Lung Health and Veterans: Philips and 4DMedical“
Join us for a focused discussion on an important partnership between two leading companies, aimed at enhancing lung healthcare accessibility for Veterans. This session will present cooperative efforts to improve cardiothoracic imaging and address healthcare needs for Veterans, including those who have been exposed to airborne toxins.
Industry leaders Jeff DiLullo (Philips) and Prof. Andreas Fouras (4DMedical) and will guide you through the innovative methodologies that leverage standard-of-care CT imaging.
Key topics will include:
The Imaging Wire: “Imaging Veterans with Toxic Exposure”
U.S. military veterans who returned from past overseas deployments have experienced a variety of breathing ailments collectively called deployment-related respiratory disease (DRRD), believed to be caused by exposure to burn pits and other airborne hazards. In this episode of The Imaging Wire Show, Brian Casey talks to one veteran about her experience, and about technologies from 4DMedical that can help screen for and diagnose DRRD.
Radiology Today: “Deep Breaths”
The article highlights how these technologies are transforming the diagnostic process, improving accuracy in detecting and characterizing various pulmonary conditions, and reducing the time burden on radiologists.
“Novel Machine Learning Algorithm Predicts All-cause Mortality in the National Lung Screening Trial”
The study, presented at ATS 2024, introduces a novel machine learning algorithm designed to predict all-cause mortality among participants in the National Lung Screening Trial. This algorithm leverages a comprehensive set of variables, including imaging data and clinical information, to enhance predictive accuracy. By integrating these diverse data sources, the algorithm provides a robust tool for stratifying patient risk, potentially guiding clinical decision-making and optimizing patient management. Radiologists may find this approach particularly valuable as it highlights the potential of machine learning in augmenting traditional imaging practices and improving patient care outcomes in lung cancer screening programs.
Population Health Screening—Identifying and Re-engaging At-risk Patients
Emphysema and COPD are underdiagnosed in up to 50% of patients, and often not identified until advanced stages. For these patients, options like Bronchoscopic Lung Volume Reduction (BLVR) or Lung Volume Reduction Surgery (LVRS) can have a significantly positive impact on a patient’s quality of life.
B4 Symptoms, in collaboration with Lahey Hospital and Medical Center, a B4-sponsored pilot site, initiated a comprehensive screening program using 4DMedical’s advanced imaging analysis software, based on Imbio Technology. This program aims to identify patients who could benefit from BLVR and LVRS therapies for advanced emphysema.
